Pharmaceutical News

RSS

GLP-1 drugs found to lower cancer risk in diabetes patients

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

8 Jul 2024

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

A study from the University of Nottingham shows that combining Semaglutide with a very-low calorie diet significantly improves weight loss and glycemic control in type 2 diabetes patients.

8 Jul 2024

Understanding the reach of pharmaceutical promotional events in healthcare

Promotional events sponsored by the pharmaceutical industry which target health professionals responsible for prescribing medications, such as physicians and nurse practitioners, are a key component of promotional campaigns for new drugs and devices.

8 Jul 2024

First-in-class oral drug improves embryo implantation and pregnancy outcomes in IVF

New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

8 Jul 2024

COVID-19 vaccination linked to reduced symptomatic child asthma

Researchers found that higher COVID-19 vaccination rates are linked to reduced asthma symptoms in children, highlighting broader health benefits of vaccination during the pandemic.

8 Jul 2024

Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses

Researchers discovered that interferon-stimulated SAMD9L restricts HIV-1 and other lentiviruses by inhibiting viral translation and endosomal trafficking, while SAMD9 enhances HIV-1 replication.

7 Jul 2024

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the second preclinical candidate compound (PCC) in its collaboration with Fosun Pharma in June 2024, a potential innovative therapeutic using synthetic lethal strategy for the treatment of solid tumors.

5 Jul 2024

Novel compound amplifies naloxone's power to reverse overdoses

In a Stanford Medicine-led study, researchers combed through billions of compounds to find one that could enhance naloxone’s ability to fend off more potent opioids, with promising results in mice.

4 Jul 2024

Repurposing cancer drug to prevent organ damage in infectious diseases

Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue.

3 Jul 2024

Researchers identify potential drugs that make naloxone more potent and longer lasting

The ongoing opioid epidemic in the U.S. kills tens of thousands of people every year. Naloxone, sold under the brand name Narcan, has saved countless lives by reversing opioid overdoses.

3 Jul 2024

Research could help drug developers improve the safety profiles of medications

Research from the University of British Columbia, MIT, and the University of Michigan could help drug developers improve the safety profiles of medications and reduce side effects.

3 Jul 2024

Low-dose aspirin shows promise in treating flu-related vascular inflammation during pregnancy

A world-first study has found low-dose aspirin may treat flu-induced blood vessel inflammation, creating better blood flow to the placenta during pregnancy.

2 Jul 2024

SRI’s novel injectable formulation aims to provide a better option to fight malaria

SRI today announced that researchers are developing a new treatment that aims to provide a better option to fight malaria, particularly for people in low-income and rural regions.

2 Jul 2024

Visible light technique simplifies synthesis of key pharmaceutical building blocks

University of Michigan chemists have discovered a way to use visible light to synthesize a class of compounds particularly well suited for use in pharmaceuticals.

2 Jul 2024

Senolytic drugs are not a "one-size-fits-all" remedy and may benefit some older women

Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a "one-size-fits-all" remedy, Mayo Clinic researchers have found.

2 Jul 2024

New study reveals key to more effective antihistamines

Even if two molecules have the exact same chemical formula and the same number and types of bonds, their three-dimensional arrangements can still be different.

1 Jul 2024

Radiometer celebrates 70 years in acute care diagnostics

In 1954, Radiometer launched the world’s first commercially available blood gas analyzer. This event catapulted a small Danish company that produced devices for the radio industry into the foray of acute care diagnostics.

From Radiometer Medical 1 Jul 2024

Showcasing neuroprotective effects of citicoline at NUTRITION 2024

Kyowa Hakko Bio Co., Ltd. and Kirin Holdings Company, Limited are thrilled to announce their sponsored satellite program at the American Society for Nutrition's (ASN) Annual Conference, NUTRITION 2024.

28 Jun 2024

Google searches reveal growing interest in microdosing amid changing drug policies

Loosening local, state and federal regulations on cannabis and psychedelics has increased Americans' interest in microdosing, according to a study from researchers at the University of California San Diego.

28 Jun 2024

Psilocybin mushrooms in America: Usage trends and policy implications

Psilocybin mushrooms are the psychedelic substance most often used in the U.S., with its popularity outpacing other psychedelic drugs such as MDMA (known as ecstasy), according to a new RAND report.

27 Jun 2024

Previous
1
...
21
22
23
24
25
26
27
...
1443
Next

Pharmaceutical News

GLP-1 drugs found to lower cancer risk in diabetes patients

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

Understanding the reach of pharmaceutical promotional events in healthcare

First-in-class oral drug improves embryo implantation and pregnancy outcomes in IVF

COVID-19 vaccination linked to reduced symptomatic child asthma

Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Novel compound amplifies naloxone's power to reverse overdoses

Repurposing cancer drug to prevent organ damage in infectious diseases

Researchers identify potential drugs that make naloxone more potent and longer lasting

Research could help drug developers improve the safety profiles of medications

Low-dose aspirin shows promise in treating flu-related vascular inflammation during pregnancy

SRI’s novel injectable formulation aims to provide a better option to fight malaria

Visible light technique simplifies synthesis of key pharmaceutical building blocks

Senolytic drugs are not a "one-size-fits-all" remedy and may benefit some older women

New study reveals key to more effective antihistamines

Radiometer celebrates 70 years in acute care diagnostics

Showcasing neuroprotective effects of citicoline at NUTRITION 2024

Google searches reveal growing interest in microdosing amid changing drug policies

Psilocybin mushrooms in America: Usage trends and policy implications

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News